Neurocrine Biosciences, Inc (NBIX) Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio

Neurocrine Biosciences, Inc (NASDAQ: NBIX) FY 2026 M&A Release

Newsdesk: